跳至主要内容
临床试验/NCT00488501
NCT00488501已完成不适用

Clinical Usefulness and Efficacy of Intrathoracic Impedance Monitoring Using the OptiVol Patient Alert(TM) in Medtronic(R) ICD's for Early Detection of Decompensated Heart Failure

Catharina Ziekenhuis Eindhoven1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2007年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
29
试验地点
1
主要终点
clinical efficacy and value of ambulatory intrathoracic impedance measurement of the Optivol alert as an indicator of decompensated heart failure reflected by sensitivity and positive predictive value

研究概览

简要总结

In this study we investigate the clinical value and efficacy of OptiVol (TM) impedance measurements by Medtronic (R) ICD's. We aim to determine sensitivity and positive predictive value for detecting heart failure. We also investigate if left ventricular filling pattern measured by echocardiography and/or brain natriuretic peptide (BNP) level can be used to improve the positive predictive value of the Optivol alert

详细描述

Patients who have a Medtronic (R) ICD equipped with the Optivol (TM) impedance monitoring will be included in your study after informed consent. The OptiVol (TM) feature will be activated and at baseline data is collected (blood sample including BNP, electrocardiography, echocardiography, chest X-ray and ICD check-up). During follow-up patients will be re-assessed in case of an OptiVol alert or in case of heart failure.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • chronic heart failure of any cause
  • implanted Medtronic ICD with OptiVol impedance monitoring

排除标准

  • inability to receive informed consent

结局指标

主要结局

clinical efficacy and value of ambulatory intrathoracic impedance measurement of the Optivol alert as an indicator of decompensated heart failure reflected by sensitivity and positive predictive value

时间窗: end of follow-up

次要结局

  • influence of left ventricular filling pattern and brain natriuretic level on the positive predictive value of the Optivol alert(end of follow-up)

研究者

发起方
Catharina Ziekenhuis Eindhoven
申办方类型
Other

研究点 (1)

Loading locations...

相似试验